Chiron posted a robust increase in fourth-quarter sales and profits yesterday, helped by the resumption of sales for its seasonal influenza vaccine, Fluvirin, and lower taxes. Chiron posted a robust ...
Chiron still has a hurdle to climb before it can begin to re-supply its flu vaccine, Fluvirin, to the USA, according to a statement from the US Food and Drug Administration yesterday. Chiron still has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback